TBC
AGN

Three Bays Capital’s Allergan plc AGN Stock Holding History

Three Bays Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-212,297
Closed -$44.6M – 32
2016
Q4 		$44.6M Buy
212,297
+45,900
+28% +$9.51M 2.05% 15
2016
Q3 		$38.3M Sell
166,397
-389,383
-70% -$95.2M 2.54% 14
2016
Q2 		$128M Buy
555,780
+209,301
+60% +$48.3M 6.69% 6
2016
Q1 		$92.9M Sell
346,479
-141,000
-29% -$40.4M 6.01% 7
2015
Q4 		$152M Buy
487,479
+52,266
+12% +$15.6M 6.84% 6
2015
Q3 		$118M Buy
435,213
+134,974
+45% +$41.5M 5.92% 6
2015
Q2 		$91.1M Sell
300,239
-168,400
-36% -$50.2M 3.78% 8
2015
Q1 		$139M Buy
468,639
+309,239
+194% +$88.2M 5.87% 5
2014
Q4 		$41M Buy
+159,400
New +$39.8M 2.61% 10

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Three Bays Capital's AGN Position: Q1 2017 in Review

Three Bays Capital sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 212,297 shares — an estimated $44.6M sold.

Three Bays Capital first reported a position in AGN in Q4 2014 and held it in 9 quarters. The position peaked at $152M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Three Bays Capital reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Three Bays Capital sold 212,297 Allergan plc shares in Q1 2017, an estimated $44.6M.
  • Three Bays Capital first reported a position in Allergan plc in Q4 2014 and held it in 9 quarters.
  • Three Bays Capital's Allergan plc position peaked at $152M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Three Bays Capital's 13F filing for Q1 2017, filed 15 May 2017.